Dow Down0.32% Nasdaq Down0.62%

Halozyme Therapeutics, Inc. (HALO)

-NMS
10.55 Down 0.29(2.68%) Apr 29, 4:00PM EDT
|After Hours : 10.55 0.00 (0.00%) Apr 29, 4:55PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
Net Income (32,231) (68,375) (83,479)
Operating Activities, Cash Flows Provided By or Used In
Depreciation2,556  3,219  2,343  
Adjustments To Net Income22,089  17,532  9,694  
Changes In Accounts Receivables(23,261)(52)6,606  
Changes In Liabilities12,621  659  17,137  
Changes In Inventories(3,083)(236)(3,499)
Changes In Other Operating Activities(15,774)(265)1,859  
Total Cash Flow From Operating Activities (37,083) (47,518) (49,339)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(2,360)(1,368)(2,297)
Investments8,248  (31,583)(45,572)
Other Cash flows from Investing Activities -   -   -  
Total Cash Flows From Investing Activities 5,888   (32,951) (47,869)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock13,098  114,501  5,079  
Net Borrowings -   -  19,985  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 13,098   114,501   25,064  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents (18,097) 34,032   (72,144)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.